243 related articles for article (PubMed ID: 14971862)
1. Imipramine vs. sertraline in panic disorder: 24-week treatment completers.
Mavissakalian MR
Ann Clin Psychiatry; 2003; 15(3-4):171-80. PubMed ID: 14971862
[TBL] [Abstract][Full Text] [Related]
2. Sertraline versus imipramine treatment of comorbid panic disorder and major depressive disorder.
Lepola U; Arató M; Zhu Y; Austin C
J Clin Psychiatry; 2003 Jun; 64(6):654-62. PubMed ID: 12823079
[TBL] [Abstract][Full Text] [Related]
3. Switching from imipramine to sertraline in panic disorder.
Mavissakalian MR
J Psychiatr Pract; 2004 Mar; 10(2):88-94. PubMed ID: 15330404
[TBL] [Abstract][Full Text] [Related]
4. The side effects burden of extended imipramine treatment of panic disorder.
Mavissakalian MR; Perel JM
J Clin Psychopharmacol; 2000 Oct; 20(5):547-55. PubMed ID: 11001240
[TBL] [Abstract][Full Text] [Related]
5. Gauging the effectiveness of extended imipramine treatment for panic disorder with agoraphobia.
Mavissakalian MR; Perel JM; Talbott-Green M; Sloan C
Biol Psychiatry; 1998 Jun; 43(11):848-54. PubMed ID: 9611676
[TBL] [Abstract][Full Text] [Related]
6. Drug treatment for panic disorder with or without agoraphobia: systematic review and network meta-analysis of randomised controlled trials.
Chawla N; Anothaisintawee T; Charoenrungrueangchai K; Thaipisuttikul P; McKay GJ; Attia J; Thakkinstian A
BMJ; 2022 Jan; 376():e066084. PubMed ID: 35045991
[TBL] [Abstract][Full Text] [Related]
7. Specific side effects of long-term imipramine management of panic disorder.
Mavissakalian M; Perel J; Guo S
J Clin Psychopharmacol; 2002 Apr; 22(2):155-61. PubMed ID: 11910260
[TBL] [Abstract][Full Text] [Related]
8. A randomized, controlled trial of the effectiveness of cognitive-behavioral therapy and sertraline versus a waitlist control group for anxiety disorders in older adults.
Schuurmans J; Comijs H; Emmelkamp PM; Gundy CM; Weijnen I; van den Hout M; van Dyck R
Am J Geriatr Psychiatry; 2006 Mar; 14(3):255-63. PubMed ID: 16505130
[TBL] [Abstract][Full Text] [Related]
9. A 15-year follow-up study of patients with panic disorder.
Andersch S; Hetta J
Eur Psychiatry; 2003 Dec; 18(8):401-8. PubMed ID: 14680716
[TBL] [Abstract][Full Text] [Related]
10. Developments in the drug treatment of panic disorder: what is the place of the selective serotonin reuptake inhibitors?
Westenberg HG
J Affect Disord; 1996 Sep; 40(1-2):85-93. PubMed ID: 8882918
[TBL] [Abstract][Full Text] [Related]
11. Early improvement predicts endpoint remission status in sertraline and placebo treatments of panic disorder.
Pollack MH; Rapaport MH; Fayyad R; Otto MW; Nierenberg AA; Clary CM
J Psychiatr Res; 2002; 36(4):229-36. PubMed ID: 12191627
[TBL] [Abstract][Full Text] [Related]
12. Sertraline treatment of panic disorder: response in patients at risk for poor outcome.
Pollack MH; Rapaport MH; Clary CM; Mardekian J; Wolkow R
J Clin Psychiatry; 2000 Dec; 61(12):922-7. PubMed ID: 11206597
[TBL] [Abstract][Full Text] [Related]
13. The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine.
Keller MB; Gelenberg AJ; Hirschfeld RM; Rush AJ; Thase ME; Kocsis JH; Markowitz JC; Fawcett JA; Koran LM; Klein DN; Russell JM; Kornstein SG; McCullough JP; Davis SM; Harrison WM
J Clin Psychiatry; 1998 Nov; 59(11):598-607. PubMed ID: 9862606
[TBL] [Abstract][Full Text] [Related]
14. Comparison of fluvoxamine, imipramine, and placebo in the treatment of outpatients with panic disorder.
Nair NP; Bakish D; Saxena B; Amin M; Schwartz G; West TE
Anxiety; 1996; 2(4):192-8. PubMed ID: 9160622
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic effect of imipramine, paroxetine, and sertraline on 35% carbon dioxide hypersensitivity in panic patients: a double-blind, random, placebo-controlled study.
Bertani A; Perna G; Arancio C; Caldirola D; Bellodi L
J Clin Psychopharmacol; 1997 Apr; 17(2):97-101. PubMed ID: 10950471
[TBL] [Abstract][Full Text] [Related]
16. Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials.
Sussman N; Ginsberg DL; Bikoff J
J Clin Psychiatry; 2001 Apr; 62(4):256-60. PubMed ID: 11379839
[TBL] [Abstract][Full Text] [Related]
17. Treatment of panic disorder with agoraphobia: randomized placebo-controlled trial of four psychosocial treatments combined with imipramine or placebo.
Marchand A; Coutu MF; Dupuis G; Fleet R; Borgeat F; Todorov C; Mainguy N
Cogn Behav Ther; 2008; 37(3):146-59. PubMed ID: 18608313
[TBL] [Abstract][Full Text] [Related]
18. Gender differences in treatment response to sertraline versus imipramine in chronic depression.
Kornstein SG; Schatzberg AF; Thase ME; Yonkers KA; McCullough JP; Keitner GI; Gelenberg AJ; Davis SM; Harrison WM; Keller MB
Am J Psychiatry; 2000 Sep; 157(9):1445-52. PubMed ID: 10964861
[TBL] [Abstract][Full Text] [Related]
19. Are SSRIs and TCAs equally effective for the treatment of panic disorder?
Brokaw DK
J Fam Pract; 2002 Mar; 51(3):279. PubMed ID: 11978241
[No Abstract] [Full Text] [Related]
20. Rational treatment of panic disorder with antidepressants.
Mavissakalian MR; Ryan MT
Ann Clin Psychiatry; 1998 Dec; 10(4):185-95. PubMed ID: 9988061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
